Breast Cancer BRAs Study (Breast Cancer Biomechanics of Radiotherapy And Surgery)
NCT ID: NCT07135960
Last Updated: 2025-08-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
45 participants
OBSERVATIONAL
2025-02-06
2026-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Radiation Therapy After Surgery in Treating Women With Early Stage Breast Cancer
NCT00005588
Radiation Therapy After Surgery in Treating Women With Early Stage Breast Cancer
NCT00005587
Evaluation of the Effectiveness of Prepectoral Breast Reconstruction
NCT05125991
Simulating Outcomes From Breast Conserving Surgery Using 3D Surface Imaging
NCT03250260
Whole Breast + Lymph Node Irradiation: Prone Compared to Supine Position in 15 or 5 Fractions
NCT03280719
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients who would be eligible to participate in this study include women aged 18 or treated with surgery +/- radiotherapy for breast cancer that affects one of their breasts. Patients will be recruited from the Breast Unit at Queen Alexandra Hospital, Cosham. Participation in this study will involve attending the biomechanics testing laboratory at UoP after their surgery and/or after radiotherapy, and optionally before surgery too. 3D scans and sensors will be used to assess the structure and movement of the breast. Participants will be asked their views on the testing methods, as well as their bra requirements and exercise habits before and after breast cancer treatment. The information generated from this study could be used in the future to help design better bras for women treated for breast cancer. It could also help women make decisions about treatment based on evidence about how the breast is likely to move differently afterwards and improve satisfaction with treatment outcomes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Participants with relevant condition
No interventions assigned to this group
Women aged 18 or treated with surgery +/- radiotherapy for breast cancer that affects one of their b
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 years of age or above
* Early or locally advanced breast cancer classified as B5a or B5b (radical treatment intent)
* Unilateral breast cancer (contralateral breast used as control)
* Receiving or has received breast cancer surgery
* +/- Adjuvant radiotherapy
* Able to travel to the University of Portsmouth Breast biomechanics laboratory
* Participant has capacity to consent.
Exclusion Criteria
* \< 2 weeks post-operative
* \< 4 weeks post-radiotherapy
* Active post-operative breast infection
* Requirement of ongoing breast dressings
* Previous breast surgery to contralateral breast
* Bilateral breast cancer
* Epilepsy (due to strobe on 3D scanner)
* Pregnancy or \<6 weeks post-partum
* Breastfeeding
* Rockwood Frailty score \>5 (or those unable to ambulate un-aided)
* Requiring interpreter.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Portsmouth
OTHER
Portsmouth Hospitals NHS Trust
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Edward St John
Role: PRINCIPAL_INVESTIGATOR
Portsmouth Hospitals University NHS Trust
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Queen Alexandra Hospital
Portsmouth, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PHU/2024/32
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.